Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.2807/1560-7917.ES.2025.30.19.2400185 | ||||
| Año | 2025 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background: Evidence-informed public health decision-making (EIDM) is a complex process that must consider multiple factors. Aim: We aimed to identify and describe existing frameworks supporting evidence-informed public health decision-making and their application to infectious disease. Methods: We conducted a scoping review to describe current EIDM framework use in public health. We included decision-making frameworks in public health and examples of their use in infectious diseases. We searched MEDLINE and Health Systems Evidence from inception to December 2022. We also hand searched websites of relevant organisations and conducted a forward citation search of the included frameworks. Two reviewers selected studies independently, one reviewer extracted data and one cross-checked for accuracy. We presented the results narratively. Results: We included 15 frameworks. Seven had a generic scope and eight were focused on specific topics (immunisation, COVID-19 or other, non-infectious diseases). From the included frameworks, we identified a total of 18 criteria with each framework assessing a median of eight, the most frequent being 'desirable effects', 'resources considerations' and 'feasibility'. We identified infectious disease examples for four frameworks: 'Grading of Recommendations, Assessment, Development, and Evaluation' (GRADE), WHO-INTEGRATe Evidence (WHO-INTEGRATE), 'Ethics, Equity, Feasibility, and Acceptability' (EEFA) and 'Community Preventive Services Task Force' (CPSTF) evidence-to-decision frameworks. Conclusion: Although several EIDM frameworks exist for public health decision-making, most have not been widely applied to infectious diseases. Current EIDM frameworks inconsistently address factors for public health decision-making. Further application and evaluation, and possibly adaptation of existing frameworks, is required to optimise decision-making in public health and infectious diseases.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Song, Yang | - |
Chinese Univ Hong Kong - China
Ctr Cochrane Iberoamericano - España The Chinese University of Hong Kong, Shenzhen - China |
| 2 | Bracchiglione, Javier | - |
Ctr Cochrane Iberoamericano - España
Inst Recerca St Pau IR SANT PAU - España Inst Salud Carlos III - España Universidad de Valparaíso - Chile Institut de Recerca Sant Pau (IR SANT PAU) - España Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública - España |
| 3 | Meneses-Echavez, Jose | - |
Universidad Santo Tomás - Colombia
Norwegian Inst Publ Hlth - Noruega Folkehelseinstituttet - Noruega |
| 4 | Gomes, Helena de Carvalho | - |
European Ctr Dis Prevent & Control ECDC - Suecia
European Centre for Disease Prevention and Control - Suecia |
| 5 | Albiger, Barbara | - |
European Ctr Dis Prevent & Control ECDC - Suecia
European Centre for Disease Prevention and Control - Suecia |
| 6 | Sola, Ivan | - |
Ctr Cochrane Iberoamericano - España
Inst Recerca St Pau IR SANT PAU - España Inst Salud Carlos III - España Institut de Recerca Sant Pau (IR SANT PAU) - España Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública - España |
| 7 | Rigau, David | - |
Ctr Cochrane Iberoamericano - España
Inst Recerca St Pau IR SANT PAU - España Institut de Recerca Sant Pau (IR SANT PAU) - España |
| 8 | Alonso-Coello, Pablo | - |
Ctr Cochrane Iberoamericano - España
Inst Recerca St Pau IR SANT PAU - España Inst Salud Carlos III - España Institut de Recerca Sant Pau (IR SANT PAU) - España Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública - España |
| Fuente |
|---|
| European Centre for Disease Prevention and Control |
| European Centre for Disease Prevention and Control (ECDC) |
| Agradecimiento |
|---|
| This study has been funded by the European Centre for Disease Prevention and Control (ECDC) . The funding source provided feedback for the study design; collection, analysis and interpretation of data; writing of the report; and was involved in the decision to submit the article for publication. |
| This study has been funded by the European Centre for Disease Prevention and Control (ECDC). The funding source provided feedback for the study design; collection, analysis and interpretation of data; writing of the report; and was involved in the decision to submit the article for publication. |